Valuation: Novartis AG

Market Cap 304B 1,568B 261B 245B 224B 422B 28,977B 424B 2,896B 1,122B 14,619B 1,141B 1,116B 48,418B P/E 2026 *
22.7x
P/E 2027 * 19.4x
Enterprise Value 336B 1,736B 289B 271B 248B 467B 32,094B 470B 3,208B 1,243B 16,191B 1,263B 1,236B 53,627B EV / Sales 2026 *
5.84x
EV / Sales 2027 * 5.41x
Free-Float
91.66%
Yield 2026 *
2.73%
Yield 2027 * 2.85%
1 day+4.29%
1 week+4.29%
Current month+2.61%
1 month+2.00%
3 months+8.15%
6 months-3.77%
Current year+7.27%
1 week 75.88
Extreme 75.88
82.25
1 month 75.88
Extreme 75.88
82.25
Current year 69.28
Extreme 69.28
87.3
1 year 65.03
Extreme 65.03
87.3
3 years 45.6
Extreme 45.6
87.3
5 years 39.32
Extreme 39.32
87.3
10 years 39.32
Extreme 39.32
87.3
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.29%+4.29% - - 304B
-3.27%-6.78%+62.17%+115.48% 1,100B
-1.15%-1.22%+53.02%+64.39% 658B
-1.64%-1.86%+25.28%+77.05% 470B
-1.47%+0.24%+42.09%+42.12% 372B
-0.90%+0.05%+25.57%+40.59% 304B
-1.94%+1.53%+3.05%+13.24% 264B
-0.21%-0.25%+52.38%+72.00% 239B
-0.93%+1.84%-13.11%-52.83% 213B
-0.09%+0.63%+29.43%+92.79% 184B
Average -0.69%+3.01%+31.10%+51.65% 422.54B
Weighted average by Cap. -1.29%+2.21%+40.63%+68.41%

Financials

2026 *2027 *
Net sales 57.65B 297B 49.48B 46.44B 42.42B 80.05B 5,498B 80.44B 550B 213B 2,774B 216B 212B 9,188B 61.31B 316B 52.62B 49.39B 45.11B 85.13B 5,848B 85.54B 584B 227B 2,950B 230B 225B 9,771B
Net income 13.95B 71.99B 11.97B 11.24B 10.26B 19.37B 1,331B 19.47B 133B 51.54B 671B 52.38B 51.24B 2,223B 15.5B 79.99B 13.31B 12.49B 11.41B 21.53B 1,479B 21.63B 148B 57.27B 746B 58.2B 56.94B 2,471B
Net Debt 32.68B 169B 28.05B 26.33B 24.05B 45.38B 3,117B 45.6B 312B 121B 1,572B 123B 120B 5,208B 27.82B 144B 23.88B 22.41B 20.47B 38.63B 2,653B 38.81B 265B 103B 1,339B 104B 102B 4,433B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26-08-26 R$81.76 +4.29% 1
26-08-25 R$82.08 +8.17% 20
26-08-24 R$75.88 -3.21% 9
26-08-19 R$78.40 -2.00% 1
26-08-18 R$80.00 +1.32% 1
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
159.84USD
Average target price
154.32USD
Spread / Average Target
-3.45%

Quarterly revenue - Rate of surprise